Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
TCTactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc. (TCMD)

NASDAQ Global Market · Currency in USD
$23.39 ▼ -0.25 (-1.06%)
At close: Oct 26, 4:00 PM ET. Market closed.
$23.39 ▲ +0.00 (+0.00%)
After hours: Oct 26, 4:10 PM ET

Summary

Previous Close
$23.64
Open
$23.55
Day's Range
$23.34 – $23.83
52 Week Range
$14.84 – $37.77
Volume
162,481
Avg. Volume
281,326
Market Cap
$529.84M
Beta (5Y Monthly)
0.82
PE Ratio (TTM)
21.46
EPS (TTM)
$1.10
Earnings Date
Nov 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$35.00

Profile: Tactile Systems Technology, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
1,086
CEO
Sheri Louise Dodd

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers.

Earnings

Next report: Mon, Nov 2, 2026
EPS estimate $0.30 · Revenue est. $91.99M
DateEst.Actual
Aug 10, 2026$0.14$0.34Beat
May 4, 2026-$0.07-$0.08Miss
Feb 17, 2026$0.44$0.46Beat
Nov 3, 2025$0.16$0.36Beat
Aug 4, 2025$0.09$0.14Beat
May 5, 2025-$0.07-$0.13Miss

Analyst view

Consensus price target
$35.00 ▲ +49.6%
Range $35.00 – $35.00
Rating: Buy
Buy 73% · Hold 9% · Sell 18%

Similar stocks

Get free alerts on TCMD and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.